The mechanistic study clearly revealed that PLOD3 knockdown inhibits STAT3 activation, suggesting that inactivation of STAT3 signaling by PLOD3 may serve as an effective therapeutic approach for lung cancer. This evidence concerns the gene STAT3 and lung carcinoma.